Adtran
ADTN
172 hedge funds and large institutions have $875M invested in Adtran in 2016 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 58 reducing their positions, and 16 closing their positions.
81% more call options, than puts
Call options by funds: $2.36M | Put options by funds: $1.3M
63% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 16
5% more funds holding
Funds holding: 164 → 172 (+8)
2% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 58
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less capital invested
Capital invested by funds: $970M → $875M (-$95.3M)
Top Buyers
Top Sellers
ADTN Hedge Fund Activity: Q2 2016 in Review
172 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Adtran (ADTN) for Q2 2016, worth a combined $875M — down 9.8% from $970M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new ADTN positions and 16 closed out — a net gain of 10 holders — while 59 added to existing stakes and 58 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $13.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $37.4M.
- 172 institutional investors held Adtran (ADTN) as of Q2 2016, up from 164 in Q1 2016.
- Funds reported $875M of Adtran stock for Q2 2016, down 9.8% quarter-over-quarter.
- 26 funds opened new Adtran positions in Q2 2016 and 16 closed out, a net change of +10 holders.
- The largest Adtran buyer in Q2 2016 was Citadel Advisors, an estimated $13.3M added.
- The largest Adtran seller in Q2 2016 was T. Rowe Price Associates, an estimated $37.4M sold.
Based on aggregated 13F filings for Q2 2016.